Polymorphisms of the BDNF gene show neither association with multiple sclerosis susceptibility nor clinical course

Journal of Neuroimmunology

Volumn 244, Issue 1-2, 2012, Pages 107-110

  Mero, Inger Lise ^a,b   Smestad, Cathrine ^a   Lie, Benedicte A ^b   Lorentzen, Åslaug R ^a,c   Sandvik, Leiv ^a   Landrø, Nils Inge ^c   Aarseth, Jan H ^d   Myhr, Kjell Morten ^d,e   Celius, Elisabeth G ^a   Harbo, Hanne F ^a,c  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^e UNIVERSITY OF BERGEN   (Norway)

Author keywords

BDNF; Clinical outcome; MS

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; DNA; METHIONINE; VALINE;

ADULT; ARTICLE; BRAIN DERIVED NEUROTROPHIC FACTOR GENE; COGNITIVE DEFECT; CONTROLLED STUDY; DEMOGRAPHY; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; GENE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS SEVERITY SCALE; NORWAY; ONSET AGE; PRIORITY JOURNAL; PROTEIN FUNCTION; RATING SCALE; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGE OF ONSET; BRAIN-DERIVED NEUROTROPHIC FACTOR; DISEASE PROGRESSION; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; METHIONINE; MULTIPLE SCLEROSIS; NORWAY; POLYMORPHISM, GENETIC; VALINE;

EID: 84857922939     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2012.01.011     Document Type: Article

References (21)

1. Blanco Y., Gomez-Choco M., Arostegui J.L., Casanova B., Martinez-Rodriguez J.E., Bosca I., Munteis E., Yague J., Graus F., Saiz A. No association of the Val66Met polymorphism of brain-derived neurotrophic factor (BDNF) to multiple sclerosis. Neurosci. Lett. 2006, 396:217-219.
2. Cerasa A., Tongiorgi E., Fera F., Gioia M.C., Valentino P., Liguori M., Manna I., Zito G., Passamonti L., Nistico R., Quattrone A. The effects of BDNF Val66Met polymorphism on brain function in controls and patients with multiple sclerosis: an imaging genetic study. Behav. Brain Res. 2010, 207:377-386.
3. Dupont W.D., Plummer W.D. Power and sample size calculations. A review and computer program. Control. Clin. Trials 1990, 11:116-128.
4. Egan M.F., Kojima M., Callicott J.H., Goldberg T.E., Kolachana B.S., Bertolino A., Zaitsev E., Gold B., Goldman D., Dean M., Lu B., Weinberger D.R. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003, 112:257-269.
5. Hofer M.M., Barde Y.A. Brain-derived neurotrophic factor prevents neuronal death in vivo. Nature 1988, 331:261-262.
6. Lalive P.H., Kantengwa S., Benkhoucha M., Juillard C., Chofflon M. Interferon-beta induces brain-derived neurotrophic factor in peripheral blood mononuclear cells of multiple sclerosis patients. J. Neuroimmunol. 2008, 197:147-151.
7. Lindquist S., Schott B.H., Ban M., Compston D.A., Sawcer S., Sailer M. The BDNF-Val66Met polymorphism: implications for susceptibility to multiple sclerosis and severity of disease. J. Neuroimmunol. 2005, 167:183-185.
8. Lindquist S., Hassinger S., Lindquist J.A., Sailer M. The balance of pro-inflammatory and trophic factors in multiple sclerosis patients: effects of acute relapse and immunomodulatory treatment. Mult. Scler. 2011, 17:851-866.
9. Makar T.K., Bever C.T., Singh I.S., Royal W., Sahu S.N., Sura T.P., Sultana S., Sura K.T., Patel N., Dhib-Jalbut S., Trisler D. Brain-derived neurotrophic factor gene delivery in an animal model of multiple sclerosis using bone marrow stem cells as a vehicle. J. Neuroimmunol. 2009, 210:40-51.
10. Mirowska-Guzel D., Mach A., Gromadzka G., Czlonkowski A., Czlonkowska A. BDNF A196G and C270T gene polymorphisms and susceptibility to multiple sclerosis in the Polish population. Gender differences. J. Neuroimmunol. 2008, 193:170-172.
11. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A., Bender D., Maller J., Sklar P., de Bakker P.I., Daly M.J., Sham P.C. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 2007, 81:559-575.
12. Ramagopalan S.V., Deluca G.C., Degenhardt A., Ebers G.C. The genetics of clinical outcome in multiple sclerosis. J. Neuroimmunol. 2008, 201-202:183-199.
13. Riemenschneider M., Schwarz S., Wagenpfeil S., Diehl J., Muller U., Forstl H., Kurz A. A polymorphism of the brain-derived neurotrophic factor (BDNF) is associated with Alzheimer's disease in patients lacking the apolipoprotein E epsilon4 allele. Mol. Psychiatry 2002, 7:782-785.
14. Roxburgh R.H., Seaman S.R., Masterman T., Hensiek A.E., Sawcer S.J., Vukusic S., Achiti I., Confavreux C., Coustans M., le, P.E., Edan G., McDonnell G.V., Hawkins S., Trojano M., Liguori M., Cocco E., Marrosu M.G., Tesser F., Leone M.A., Weber A., Zipp F., Miterski B., Epplen J.T., Oturai A., Sorensen P.S., Celius E.G., Lara N.T., Montalban X., Villoslada P., Silva A.M., Marta M., Leite I., Dubois B., Rubio J., Butzkueven H., Kilpatrick T., Mycko M.P., Selmaj K.W., Rio M.E., Sa M., Salemi G., Savettieri G., Hillert J., Compston D.A. Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity. Neurology 2005, 64:1144-1151.
15. Smestad C., Sandvik L., Landro N.I., Celius E.G. Cognitive impairment after three decades of multiple sclerosis. Eur. J. Neurol. 2010, 17:499-505.
16. Sombekke M.H., Arteta D., van de Wiel M.A., Crusius J.B., Tejedor D., Killestein J., Martinez A., Pena A.S., Polman C.H., Uitdehaag B.M. Analysis of multiple candidate genes in association with phenotypes of multiple sclerosis. Mult. Scler. 2010, 16:652-659.
17. The International Multiple Sclerosis Consortium (IMSGC) and Wellcome Trust Case Control Consortium 2 (WTCCC2) Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011, 476:214-219.
18. Wellcome Trust Case Control Consortium Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007, 447:661-678.
19. Yan Q., Elliott J., Snider W.D. Brain-derived neurotrophic factor rescues spinal motor neurons from axotomy-induced cell death. Nature 1992, 360:753-755.
20. Ziemssen T., Kumpfel T., Klinkert W.E., Neuhaus O., Hohlfeld R. Glatiramer acetate-specific T-helper 1- and 2-type cell lines produce BDNF: implications for multiple sclerosis therapy. Brain-derived neurotrophic factor. Brain 2002, 125:2381-2391.
21. Zivadinov R., Weinstock-Guttman B., Benedict R., Tamano-Blanco M., Hussein S., Abdelrahman N., Durfee J., Ramanathan M. Preservation of gray matter volume in multiple sclerosis patients with the Met allele of the rs6265 (Val66Met) SNP of brain-derived neurotrophic factor. Hum. Mol. Genet. 2007, 16:2659-2668.